Back to Search
Start Over
BM-MSCs delay the senescence of naive CD8+T cells
- Source :
- Jichu yixue yu linchuang, Vol 44, Iss 5, Pp 683-689 (2024)
- Publication Year :
- 2024
- Publisher :
- Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College., 2024.
-
Abstract
- Objective To verify the effect of bone marrow mesenchymal stem cells (BM-MSCs) in alleviating immune senescence, and to explore the main immune cell population improved by BM-MSCs. Methods Mouse spleen lymphocytes were isolated and stimulated to proliferate for 7 days for constructing a replicative aging model. Flow cytometry was used to detect the p16ink4a(p16) and p21cip1(p21) expression by T cell subpopulation in the young control group, the replicative senescence control group and the BM-MSCs co-cultured group. Results In the replicative senescence model of T lymphocytes, it was observed that CD8+T cells senescent significantly as compared with CD4+T cells after continuous proliferation. Among the naive cells and effector cell subsets of CD8+T cells, effector cell senescence was the most significant. BM-MSCs co-culture had no significant effect on senescent effector cells, and mainly alleviated the senescence of CD8+T cells by delaying the senescence of naive T cells(P<0.01,P<0.001). Conclusions BM-MSCs co-culture can alleviate the replicative senescence phenotype of T cells and has a more significant anti-senescence effect on CD8+T cells by inhibiting the initial senescence of T cells as a major mechcanism.
- Subjects :
- bone marrow mesenchymal stem cells (bm-mscs)
t cell senescence
anti-aging
Medicine
Subjects
Details
- Language :
- Chinese
- ISSN :
- 10016325
- Volume :
- 44
- Issue :
- 5
- Database :
- Directory of Open Access Journals
- Journal :
- Jichu yixue yu linchuang
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.011c6a167bc4491aba28b1c3b04b1bc
- Document Type :
- article
- Full Text :
- https://doi.org/10.16352/j.issn.1001-6325.2024.05.0683